Browse

You are looking at 1 - 4 of 4 items for :

  • Ethics, society, and public policy x
  • Refine by Content Type: All x
Clear All Modify Search

Reaffirming that race is a social, not a biological, construct, ASN remains committed to ensuring that racial and ethnic biases do not affect the diagnosis and treatment of kidney diseases.

Taking part in the 9th Annual Kidney Health Advocacy Day, advocates from the American Association of Kidney Patients (AAKP) and ASN are urging their congressional delegations to increase funding for kidney research at the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to drive new breakthroughs for kidney patients and study the impact of COVID-19 on kidney health and people with kidney diseases.

Advocates from the American Association of Kidney Patients (AAKP) and ASN are calling on Congress to include funding for KidneyX in its annual government funding legislation and advance innovative technologies for kidney patients, such as a wearable or implantable artificial kidney.

David White

Final rule applies new standards to organ procurement in the U.S.

The U.S. Department of Health and Human Services (HHS) today took action to increase donation rates and organ transplantation rates by applying new standards of accountability and transparency to the nation’s Organ Procurement Organizations (OPOs).  HHS finalized the Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organization rule that was proposed earlier this year by the Centers for Medicare and Medicaid Services (CMS).